Polymorphism of 2,5‐[(diphenylphosphanyl)methyl]‐1,1,2,4,4,5‐hexaphenyl‐1,4‐diphospha‐2,5‐diboracyclohexane

2,5‐[(Diphenylphosphanyl)methyl]‐1,1,2,4,4,5‐hexaphenyl‐1,4‐diphospha‐2,5‐diboracyclohexane shows polymorphism as two tetrahydrofuran (THF) disolvates [C₆₄H₅₈B₂P₄·2C₄H₈O, (Ia) and (Ib)] and pseudo‐polymorphism as its toluene monosolvate [C₆₄H₅₈B₂P₄·C₇H₈, (Ic)]. In each of polymorphs (Ia) and (Ib), the diphosphadiboracyclohexane molecule is located on a centre of inversion. The THF molecule of (Ib) is disordered over two sites, with a site‐occupation factor of 0.612 (8) for the major‐occupied site. Both structures crystallize in the same space group (P2₁/n), but they display a different crystal packing. For pseudo‐polymorph (Ic), although the space group is P2₁/c, which is just a different setting of the P2₁/n space group of (Ia) and (Ib), the crystal packing is completely different. Although the crystal packing in these three structures is significantly different, their molecular conformations are surprisingly the same.     

Automated clustering of probe molecules from solvent mapping of protein surfaces: new algorithms applied to hot-spot mapping and structure-based drug design

Use of solvent mapping, based on multiple-copy minimization (MCM) techniques, is common in structure-based drug discovery. The minima of small-molecule probes define locations for complementary interactions within a binding pocket. Here, we present improved methods for MCM. In particular, a Jarvis-Patrick (JP) method is outlined for grouping the final locations of minimized probes into physical clusters. This algorithm has been tested through a study of protein-protein interfaces, showing the process to be robust, deterministic, and fast in the mapping of protein "hot spots." Improvements in the initial placement of probe molecules are also described. A final application to HIV-1 protease shows how our automated technique can be used to partition data too complicated to analyze by hand. These new automated methods may be easily and quickly extended to other protein systems, and our clustering methodology may be readily incorporated into other clustering packages.     

利用一个通用的方法全合成Fuscinarin和Fuscins

通过一个共同的中间体6,首次全合成了fuscinarin (1)和全合成了fuscins,它们都是戊烯酮(pentaketide)的代谢物,在亲近闪烁检测(scintillation proximity assay)中显示具有抗CCR5的活性。这一合成主要是利用微波辅助的 ortho-Claisen/Cope 重排的串联反应更合成中间体10。     

VO2热致变色薄膜的结构和光电特性研究

用磁控溅射方法制备了VO₂热致变色薄膜.用X射线衍射、X射线光电子谱和原子力显微镜对薄膜的宏观及微观结构进行了分析，表明VO₂薄膜纯度高、相结构单一、结晶度好.薄膜的光透过率在2000nm处相变前后改变了42%，高/低温电阻率变化达到三个数量级以上.薄膜的光透过谱和相变过程中电学性质变化的研究与结构分析结果相一致. 关键词：     

The inverse sandwich complex [(K(18-crown-6))2Cp][CpFe(CO)2]--unpredictable redox reactions of [CpFe(CO)2]I with the silanides Na[SiRtBu2] (R = Me, tBu) and the isoelectronic phosphanyl borohydride K[PtBu2BH3

The dimeric iron carbonyl [CpFe(CO)(2)](2) and the iodosilanes tBu(2)RSiI were obtained from the reaction of [CpFe(CO)(2)]I with the silanides Na[SiRtBu(2)] (R = Me, tBu) in THF. By the reactions of [CpFe(CO)(2)]I and Na[SiRtBu(2)] (R = Me, tBu) the disilanes tBu(2)RSiSiRtBu(2) (R = Me, tBu) were additionally formed using more than one equivalent of the silanide. In this context it should be noted that reduction of [CpFe(CO)(2)](2) with Na[SitBu(3)] gives the disilanes tBu(3)SiSitBu(3) along with the sodium ferrate [(Na(18-crown-6))(2)Cp][CpFe(CO)(2)]. The potassium analogue [(K(18-crown-6))(2)Cp][CpFe(CO)(2)] (orthorhombic, space group Pmc2(1)), however, could be isolated as a minor product from the reaction of [CpFe(CO)(2)]I with [K(18-crown-6)][PtBu(2)BH(3)]. The reaction of [CpFe(CO)(2)](2) with the potassium benzophenone ketyl radical and subsequent treatment with 18-crown-6 yielded the ferrate [K(18-crown-6)][CpFe(CO)(2)] in THF at room temperature. The crown ether complex [K(18-crown-6)][CpFe(CO)(2)] was analyzed using X-ray crystallography (orthorhombic, space group Pna2(1)) and its thermal behaviour was investigated.     

An Unpredictable Reaction of <Emphasis Type="Italic">t</Emphasis>Bu<Subscript>2</Subscript>PHO·BCl<Subscript>3</Subscript> in the Presence of Water

Abstract  

When a benzene solution of tBu₂PHO·BCl₃ was exposed to air at room temperature, the phosphonium chloride [tBu₂PH₂]Cl was formed together with di-tert-butylphosphinic acid, tBu₂PO(OH). X-ray quality crystals of the hydrochloride [tBu₂PH₂]Cl·HCl were obtained from the reaction solution at room temperature. The hydrochloride [tBu₂PH₂]Cl·HCl crystallizes in the monoclinic space group P2₁ /m, a = 6.3012(7) ?, b = 6.8970(10) ?, c = 14.5011(15) ?, β = 99.376(9)°, V = 621.79(13) ?³, Z = 2, d _calcd = g cm⁻³ 1.165; R1 = 0.0510, wR2 = 0.1503 for 1,129 reflections with I > 2σ(I). The crystal was a non-merohedral twin with a contribution of 0.353(7) of the minor component. The structure is composed of discrete di-t-butylphosphonium cations and Cl anions. Both are located on a crystallographic mirror plane and are connected by P–H···Cl hydrogen bonds.     

The pentanuclear Fe(II) cluster [(C5H4)6Fe5]2-: bringing together ferrocene sandwiches and homoleptic Fe(II)-cyclopentadienyl sigma-complexes

Reaction of [(fc)3(Li)6.(TMEDA)2] with FeCl2 gives the pentanuclear iron complex [(fc)3(Fe)2(Li)2.(TMEDA)2] featuring two ferra[1]ferrocenophane moieties bridged by a 1,1'-ferrocenediyl unit; the non-ferrocene Fe(II) ions are tetra-coordinate and adopt a high-spin state.     

Manufacturing immunity to disease in a test tube: the magic bullet realized

Although it took over one hundred years, Ehrlich's concept of the magic bullet is now a reality. Today, therapeutic antibodies are, arguably, the most important class of new drugs for the treatment of illnesses ranging from Alzheimer's disease to cancer. The emergence of therapeutic antibodies had to wait for advances in immunochemistry that allowed construction of antibodies in vitro. The centerpiece of the new technology is the combinatorial antibody library, which essentially allows one to synthesize an artificial immune system with a diversity that exceeds that of the natural repertoire. The construction of such libraries was perceived to be difficult because, if the natural immune system was to be used as the starting material, construction of the libraries would entail protocols that are the opposite of usual cloning. In gene cloning one starts with complexity and reduces it to a singularity. In the generation of diversity by construction of combinatorial antibody libraries, one starts with a collection of clones, randomly expands their complexity, and then returns them to recoverable singularities. The methods developed to accomplish this seemingly formidable task now allow construction of antibodies in a test tube to any antigen. These synthetic antibodies may be qualitatively and quantitatively superior to those of nature.     

A polymorph of tetrakis(acetonitrile‐κN)copper(I) tetrafluoridoborate

A P2₁2₁2₁ polymorph of the title compound, [Cu(CH₃CN)₄]BF₄, is reported. The crystal structure is very similar to the structure of the Pna2₁ polymorph reported by Jones & Crespo [Acta Cryst. (1998), C 54 , 18–20]. The anions and one of the three independent cations occupy similar positions in both polymorphs. Two of the four symmetry‐related positions of the other two cations are also identical in the two polymorphs, and the other two positions are related by mirror symmetry. The crystal used for the structure determination contained a volume fraction of 0.088 (7) of the Pna2₁ polymorph.     

铪元素及其同位素的发现：技术进步和思想发展的共同结晶

1869年，门捷列夫在第一张元素周期表中的锆元素后留出原子量为180的元素位置，预测铪与锆同族。1913年，原子序数和莫斯莱定律的提出揭示了铪元素在周期表中位置排列的实质，为铪元素的发现提供理论基础。20世纪20年代，玻尔理论的发展证实铪与锆同族，指导科学家从锆矿石中寻找铪元素。1923年，赫维西和科斯特借助X射线光谱技术发现铪元素，彰显了X射线光谱技术的独特价值。20世纪30年代以后，同位素理论和质谱技术促成了铪同位素的发现，使人们对铪元素有了新的认识。总之，铪元素及其同位素的发现是技术进步和思想发展的共同结晶。